• Nenhum resultado encontrado

Rev. Bras. Cardiol. Invasiva vol.20 número1 en a06v20n1

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Cardiol. Invasiva vol.20 número1 en a06v20n1"

Copied!
8
0
0

Texto

Loading

Imagem

Figure 2 – Decision tree of cost effectiveness between drug-eluting stents  and bare-metal stents

Referências

Documentos relacionados

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the sirolimus- eluting balloon expandable stent in the treatment of

Unfortunately, two other factors might have influenced (this time negatively) the cost-effectiveness analyses, yielding costs even higher for drug-eluting stents, were not

Although the proportion of patients receiving bare metal versus drug-eluting stents is not reported in a series, it is typically between 10 and 20% in Brazil, and this relatively

Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and

“Desfechos Tardios da Intervenção Coronária Percutânea com Stent Farmacológico em Pontes de Veia Safena – Dados do Registro InCor” (Rev Bras Cardiol Invasiva.. Ribeiro,

Agradecimento aos Revisores da Revista Brasileira de Cardiologia Invasiva – 2013 Rev Bras Cardiol

Rev Bras

RESULTS: The ten studies included in this sys- tematic review did not show any statistically signifi cant difference between the drug-eluting stents and the bare-metal stents